75 Citation Laureates named by the Institute for Scientific Information have received a Nobel Prize since 2002

LONDON, Oct. 10, 2023 /PRNewswire/ — Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today celebrates the four new Nobel Laureates who were accurately identified as potential Nobel Prize recipients. Ferenc Krausz, Moungi G. Bawendi, Louis E. Braus and Claudia Goldin were named to the Citation Laureates™ list from Clarivate™ several years before being recognized by the Nobel Assembly.

Every year, the Institute for Scientific Information (ISI)™ at Clarivate interprets the high-quality citation data in the Web of Science™ to identify researchers of Nobel class who may be future Nobel Prize recipients.

Four of this year’s Nobel Laureates in three categories (Physics, Chemistry and Economics) were identified as being of Nobel class as far back as 2012. This demonstrates that extremely high levels of citations in trusted journals can signal what the global scientific community regards as groundbreaking and of the utmost importance. Since 2002, a remarkable 75 Citation Laureates have gone on to receive a Nobel Prize.

To explain the accuracy of the ISI in identifying future Nobel Laureates, David Pendlebury, Head of Research Analysis, ISI, Clarivate, said: "We rise to the unique challenge of forecasting Nobel Prize laureates by combining data-driven quantitative analysis with the human expertise of our analysts at ISI. This approach allows us to identify potential Nobel awardees years in advance, as exemplified by the four Citation Laureates honored this year. Their groundbreaking contributions have transformed our world, and it is an honor to see them recognized with a Nobel Prize."

The four Citation Laureates named as Nobel Laureates in 2023 are:

The 2023 Nobel Prize for Physics was awarded to Pierre Agostini, Ferenc Krausz and Anne L’Huillier "for experimental methods that generate attosecond pulses of light for the study of electron dynamics in matter". ISI identified this scientific breakthrough in 2015 as deserving of a Nobel Prize, linked to Ferenc Krausz, Anne L’Huillier and Paul Corkum for their contributions to the development of attosecond physics. While Krausz and Corkum were named Citation Laureates in 2015, Anne L’Huillier declined to be included on the list. The 2023 Nobel Prize for Chemistry was awarded to Moungi G. Bawendi, Louis E. Brus and Alexey Ekimov "for the discovery and synthesis of quantum dots". ISI named two of the researchers behind this scientific breakthrough several years ago: Louis E. Brus was named a Citation Laureate in 2012 for the discovery of colloidal semiconductor nanocrystals (quantum dots), and Moungi G. Bawendi in 2020 for synthesis of nanocrystals with precise attributes for a wide range of applications in physical, biological and medical systems. The Sveriges Riksbank Prize in Economic Sciences in Memory of Alfred Nobel 2023 was awarded to Claudia Goldin "for having advanced our understanding of women’s labour market outcomes". ISI identified Claudia Goldin as a Citation Laureate in 2020, recognizing her Nobel-worthy contributions to labor economics, especially her analysis of women and the gender pay gap.

To learn more about the methodology of the Citation Laureates list, explore our Hall of Citation Laureates and discover our interviews with these exceptional researchers, please visit our website.

Notes to editors
David Pendlebury, Head of Research Analysis at the Institute for Scientific Information at Clarivate is available for interview.

About Clarivate
Clarivate is a leading global information services provider. We connect people and organizations to intelligence they can trust to transform their perspective, their work and our world. Our subscription and technology-based solutions are coupled with deep domain expertise and cover the areas of Academia & Government, Life Sciences & Healthcare and Intellectual Property. For more information, please visit clarivate.com 

Media Contact
Rebecca Krahenbuhl, External Communications Manager, Academia & Government
[email protected]

Source : Clarivate Accurately Forecasts Four New 2023 Nobel Prize Laureates

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

BEIJING, Oct. 10, 2023 /PRNewswire/ — If there’s one good thing 2023 has brought back to China, it’s been big festivals. There’s no kind of festival more plentiful than that of beer themed events, with a great many having happened in the first half of the year already.

For the first time in three years, the 2023 Jing-A 8×8 Brewing Project is back in action, with Jing-A inviting 8 leading craft breweries from China and 8 breweries representing the pioneers of New Hops from Australia and New Zealand.

From October 13th to October 14th, 16 domestic and foreign craft beer brands will gather in Beijing for a two-day beer festival. Each brewery will bring their flagship products and debut 8 innovative limited release collaboration brews. All combined, there’s a total of 136 different beers to try at 8×8.

Crazy creativity and crazy fun is the goal of Jing-A craft beer.

The beers presented at the 8×8 Brewing Project represent the cutting-edge brewing trends from around the world. From wild yeast, hazy and sour beers to craft styles you’ve never tried before, to the most popular hops and even strange brewing techniques, the festival never fails to showcase a variety of new and exciting options.

Eight novel blends, creative concepts revealed in advance

This year’s blending program includes eight globally limited beers, which will be available throughout the two-day event.

No.18 Brewing Co. & Mountain Culture: Pacific Rim Double Hazy IPA
Ye Brewing Co. & 8 Wired: The Farmhouse Sour Ale
Wild West & Bridge Road Brewers: Why fight it? Double Hazy IPA.
Hopscraft & Blackman’s Brewery: Octeabierfest
Mahanine & Hop Nation: Mahanation’s Flower
E.T. Brewery & Wildflower: Table Beer Blend
Jing-A Brewing Co. & Garage Project: Ghost Whisper NZ Style Double Hazy Thiolised IPA
Bubble Lab & Range Brewing: The other Range Double Hazy IPA

It’s all about the beers and the party at 8×8

It’s not just beer tasting to look forward to, but a whole lot of food and entertainment as well. There will be special snacks to pair said beers, and live DJs to liven up the atmosphere.

There will also be on-site nail and tattoo artists, Jing-A specialty projects, coffee with a bit of art, and much more.

Scan the QR code in the image to purchase tickets and join 8×8.

(https://mp.weixin.qq.com/mp/waerrpage?type=upgrade&appid=wxf0de81ac9b2c284a&devicetype=Windows+10&version=620603c8&lang=zh_CN&ascene=7&winzoom=1)

Source : Jing-A's 8×8 Brewing Project is Back for 2023, Tickets Are on Sale Now

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

Global Think Tanks and Collaboration to Drive Innovation and Empowerment in Women’s Health

SAN ANTONIO, Oct. 10, 2023 /PRNewswire/ — Frost & Sullivan, a renowned leader in fostering innovation and driving transformative change, proudly announces the launch of its groundbreaking "EmpowerHer" Growth Council Think Tank series. This initiative, launched in July 2023, is dedicated to tackling the monumental growth gap in women’s health, which currently stands at a staggering $17 trillion. To address this complex issue, Frost & Sullivan has brought together a diverse array of stakeholders, including experts, thought leaders, industry professionals, and key policymakers.

Frost & Sullivan Launches the EmpowerHer Program to Bridge the Growth Gap in Women’s Health

The growth gap in women’s health is a multifaceted challenge rooted in three critical areas: a lack of comprehensive clinical research, limited access to healthcare, and insufficient funding for women’s health technology. This formidable gap poses a significant obstacle to delivering effective care to women worldwide.

Burdens of Health: Cost We Can’t Ignore?

Recognizing that closing this gap requires a collective effort from society as a whole, Frost & Sullivan has taken a bold step forward with its Growth Council Think Tanks.

Growth Council Think Tanks: A Dynamic Platform for Change

Frost & Sullivan’s Growth Council Think Tank series is designed to serve as a dynamic platform for addressing these pressing issues. Over 12 months, these Think Tanks will provide a forum for experts and stakeholders to share knowledge, foster innovation, and empower women.

Reenita Das, Growth Coach & Senior Vice President at Frost & Sullivan, expressed the program’s vision, stating, "Through our Growth Council Think Tanks, we aim to empower women, improve access to quality healthcare, and contribute to the overall well-being of women across the world. By bringing together diverse perspectives and expertise, we are confident that we will create tangible outcomes and establish new benchmarks for the industry."

Key Perspectives from the Think Tank on "Top Growth Opportunities in Accelerating Women’s Health"

Reenita Das, Growth Coach & Senior Vice President at Frost & Sullivan, presented transformative perspectives on the Top Growth Opportunities in Women’s Health, including:

Tailored Approaches for Different Age Groups: Recognizing the evolving roles and priorities of women in various age groups is crucial for effective engagement and segment positioning. Gender Disparities in Heart Disease: Addressing gender disparities in heart disease requires a nuanced approach, involving research into sex-specific variations in diagnosis, treatment, and prevention. Addressing Obesity as a Neurobehavioral Disease: The future of obesity management demands a transformation in healthcare models to better support long-term strategies. Innovations in Women’s Mental Health: Beyond 2030, innovative interventions will be required to address women’s mental health, necessitating novel partnerships and groundbreaking solutions.

Key Perspectives from the Think Tank on "FDA’s Bold Vision for Women’s Health"

Reenita Das, along with Terri Cornelison, Chief Medical Officer and Director, Health of Women, Center for Devices and Radiological Health (CDRH), US Food and Drug Administration (FDA), collaborated to craft transformative perspectives, including:

Sex and Gender-Specific Clinical Trials: Clinical trials for chronic diseases should incorporate criteria tailored to the unique characteristics and needs of both men and women. Early-stage Endometriosis Diagnosis: Early tracking of menstruation cycles and expanding registries for conditions such as endometriosis are essential for improving healthcare outcomes. Advancing Women’s Health through Data: A focus on science and gender, alongside the development of longitudinal studies, will lay the foundation for holistic and personalized care for women.

Frost & Sullivan invites individuals, organizations, and industry stakeholders to actively participate in this groundbreaking initiative. Together, we can pave the way for advancements in women’s health, shape the future of healthcare delivery, and make a lasting difference in the lives of women everywhere.

For more information about Frost & Sullivan’s Women’s Health Program and the Growth Council Think Tanks, click here

About Frost & Sullivan:

Frost & Sullivan, the growth pipeline company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation, and leadership. The company’s Growth Pipeline as a Service provides the CEO and the CEO’s Growth Team with transformational strategies and best-practice models to drive the generation, evaluation, and implementation of powerful growth initiatives. Frost & Sullivan leverages over 60 years of experience in partnering with Global 1000 companies, emerging businesses, and the investment community from more than 40 offices on six continents.

Contact:
María Alejandra Briceño
Corporate Communications
E: [email protected]
https://www.frost.com/

Source : Frost & Sullivan Launches the EmpowerHer Program to Bridge the Growth Gap in Women's Health

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

LONDON, Oct. 10, 2023 /PRNewswire/ — The World’s 50 Best Bars 2023, sponsored by Perrier, has revealed the extended 51-100 list. Decided by a voting panel comprising 680 independent drinks experts, from renowned bartenders, educators and consultants to drinks writers and cocktail specialists, the extended list is a forerunner to the live unveiling of The World’s 50 Best Bars 2023 on 17 October in Singapore.

THE WORLD’S 50 BEST BARS UNVEILS LIST OF BARS RANKED FROM 51-100

The 51-100 List in Numbers 

The 51-100 list includes bars spanning 34 different cities across the world There are 14 new entries, with 3 cities featuring for the first time: Tulum, Guadalajara and Tirana USA leads with six bars across New York, Chicago and Los Angeles UK leads in Europe with five bars out of a total 17 across the continent The list includes 14 bars in Asia across Bangkok, Guangzhou, Hong Kong, New Delhi, Seoul, Singapore and Tokyo

The World’s 50 Best Bars 2023 will see the prestigious event leave Europe for the first time, heading to Singapore as it continues its mission to spotlight the world’s great cocktail cities. The extended 51-100 list continues to showcase a wider selection of the most excellent bars and destinations around the world.

New entries for 2023 include Lima’s Lady Bee (No.52), Tulum’s Arca (No.60), Guadalajara’s El Gallo Altanero (No.65), New York’s Martiny’s (No.68), Dubai’s Ergo (No.69), Mexico City’s Rayo (No.72), Toronto’s Civil Liberties (No.73), Seoul’s Bar Cham (No.75), Berlin’s Velvet (No.77), Mexico City’s Kaito del Valle (No.81), Oslo’s Svanen (No.84), Tirana’s Nouvelle Vague (No.86), Bratislava’s Mirror Bar (No.90) and Athens’ The Bar in Front of the Bar (No.98). The full list can be viewed here.

William Drew, Director of Content, 50 Best, says: "When we launched the extended list of The World’s 50 Best Bars our intention was to shine a light on an even greater cross-section of the most exceptional destinations for cocktail lovers. Now, in its seventh year, we are delighted to recognise the remarkable hospitality experiences offered by these establishments across 34 incredible cities. As we once again take to the road, leaving Europe for the first time in our history to celebrate the greatest cocktail bars in the world in the iconic city of Singapore, we extend our warmest congratulations."

For media centre access, please visit:  https://mediacentre.theworlds50best.com

Source : THE WORLD'S 50 BEST BARS UNVEILS LIST OF BARS RANKED FROM 51-100

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

YONGIN, South Korea, Oct. 10, 2023 /PRNewswire/ — GC Biopharma Corp. announced on today that it has signed Power Purchase Agreement (PPA) with SK E&S Co., Ltd on October 5th at its Ochang Plant.  

PPA is an electricity trading contract signed directly between a power generator and a customer company. Under this agreement, the company can purchase and use electricity typically generated from renewable power sources directly from the power generator. PPA is a particularly efficient power supply solution for companies, who can source electricity without having to deal with price fluctuation, while reducing greenhouse gas emissions and achieve carbon neutrality.

By signing the PPA with SK E&S, which is the first PPA signed by a Korea pharma company, CG Biopharma secured total 6.7MW of renewable electricity generated from solar energy, and this will be supplied to 3 of its production sites, namely, Ochang Plant, Eumseong Plant, and Hwasun Plant over a 20-year period starting from 2026. This will help the company reduce greenhouse gas emissions by approximately 3,600 tons every year.

Seung-ho Lim, Head of Production at GC Biopharma stated, "We are pleased to sign the PPA and take part in the commitment to RE100. We will continue our efforts to be the leader in ESG by implementing corporate social responsibilities and actively participating in the global response to the climate crisis."

"Our Renewables business holds significance as it is a way for SK E&S to support many Korean corporates achieve carbon neutrality. We are committed to expanding our renewable energy supply to help Korean companies reduce greenhouse gas emissions and implement RE100.", commented Kun-Ki Seo, Head of Renewable Business at SK E&S.

About GC Biopharma

GC Biopharma (formerly known as Green Cross Corporation) is a biopharmaceutical company that delivers life-saving and life-sustaining protein therapeutics and vaccines. Headquartered in Yongin, South Korea, GC Biopharma is one of the leading plasma protein and vaccine product manufacturers globally and has been dedicated to quality healthcare solutions for more than half a century.

This press release may contain biopharmaceuticals in forward-looking statements, which express the current beliefs and expectations of GC Biopharma’s management. Such statements do not represent any guarantee by GC Biopharma or its management of future performance and involve known and unknown risks, uncertainties and other factors. GC Biopharma undertakes no obligation to update or revise any forward-looking statement contained in this press release or any other forward-looking statements it may make, except as required by law or stock exchange rule.

GC Biopharma Contacts (Media)

Sohee Kim

[email protected]

Yelin Jun

[email protected]

Source : GC Biopharma Signs Power Purchase Agreement with SK E&S

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

finbotsAI’s credit modelling solution, creditX, will help EDOMx to build high quality credit scorecards faster, enabling more accurate risk profiling & responsible lending.

SINGAPORE and NAIROBI, Kenya, Oct. 10, 2023 /PRNewswire/ — EDOMx, a Delaware entity with Kenyan operations with a vision to enhance impact-based and thoughtful consumer credit, announced signing an agreement with Singapore-headquartered B2B SaaS FinTech, finbotsAI, to enable credit risk management using AI.

Renowned for its Mobile Money Buy Now Pay Later (BNPL) service FARAJA, which is offered to M-PESA customers and businesses in partnership with Safaricom, EDOMx becomes a pioneering adopter of cutting-edge AI-based credit risk solutions a key pillar of its business.

With creditX, finbotsAI’s AI-powered credit modelling solution, EDOMx aims to utilize advanced machine learning and AI-based algorithms to develop high accuracy scorecards that are better at quantifying risk. Additionally, creditX empowers EDOMx to develop new or refreshed custom credit models on demand, instead of spending months building them or relying on generic market scorecards.

With these new capabilities, EDOMx will be able to lend to more customers with reduced risk, resulting in responsible lending growth while scaling financial inclusion efforts.

EDOMx selected finbotsAI after an extensive evaluation of the solution. This included a Proof-of-Concept where finbotsAI built custom scorecards on creditX using EDOMx’s historical data.

"Utilizing AI technology for credit scoring aligns perfectly with our mission to provide ethical and inclusive financial services to our customers. The partnership with finbotsAI empowers us to make more accurate lending decisions, which will ultimately benefit Kenya," said Julian Kyula, Founder of EDOMx.

Samson Mutisya, Growth Director (Africa) of finbotsAI, emphasized the transformative potential of the partnership, saying, "We are proud to expand our fast-growing client base in Africa, with a marketing innovator like EDOMx. We have seen enormous success in enabling lenders to drive financial inclusion responsibly. This partnership underpins the growing demand in Africa for sophisticated technology solutions that enable economic growth and solve legacy challenges."

This milestone also marks finbotsAI’s entry into Kenya. finbotsAI’s fast growing client base now stretches to 11 countries across APAC and MEA markets.

About EDOMx

EDOMx is a Delaware entity with operations in Kenya with ambition to expand across Africa and in the USA. It is an ethical and inclusive financial services and consumer technologies company purposed on identifying high value opportunities, addressing critical challenges and transforming lives by leveraging on experience, expertise and close collaborations across private, public and non-profit sectors.

With its flagship product FARAJA, EDOMx is spearheading a shift towards creating comprehensive solutions that demonstrably fix practical problems by broadening access to Digital Financial Services.

About finbotsAI

finbotsAI is an Accel Portfolio FinTech company with a mission to help lenders drive profitable lending and financial inclusion with creditX, our AI-powered platform to rapidly build high accuracy risk scorecards.

creditX is used by lenders across 4 regions, specifically Africa, Middle East, APAC and Australia, and by the full spectrum of lending companies, including digital banks, SME lenders, agri-lenders, consumer lenders and Credit Bureaus.

finbotsAI has been recognised among ‘Top 10 FinTechs in Singapore’ at the Monetary Authority of Singapore (MAS) FinTech Awards 2022. The FinTech is also part of PwC’s Partner Programme and a Featured Partner for Tata Consultancy Services.

finbotsAI is amongst one of the first FinTechs to have completed AI Verify, the world’s first AI Governance testing framework and toolkit developed by Singapore Government’s IMDA (Infocomm Media Development Authority) and PDPC (Personal Data Protection Commission).

finbotsAI is headquartered in Singapore and has offices in India (Hyderabad), the United Arab Emirates (Dubai), Indonesia (Jakarta) and Nairobi (Kenya).

For more information on finbotsAI, click here: https://www.finbots.ai/. 

Source : EDOMx Selects Singapore Fintech finbotsAI to Scale Faraja BNPL Business & Drive Financial Inclusion with High Accuracy AI-Powered Credit Decisioning

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network